MAIA Biotechnology, Inc. (MAIA)
Automate Your Wheel Strategy on MAIA
With Tiblio's Option Bot, you can configure your own wheel strategy including MAIA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MAIA
- Rev/Share 0.0
- Book/Share 0.1785
- PB 10.9273
- Debt/Equity 0.0
- CurrentRatio 2.3454
- ROIC -2.708
- MktCap 59099262.0
- FreeCF/Share -0.5892
- PFCF -3.6213
- PE -2.7409
- Debt/Assets 0.0
- DivYield 0
- ROE -5.9006
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial
Published: June 05, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial.
Read More
MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer
Published: June 05, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer.
Read More
MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
Published: May 15, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting.
Read More
Best Momentum Stocks to Buy for May 6th
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
MAIA, BYRN and OCX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 6, 2025.
Read More
New Strong Buy Stocks for May 6th
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
MAIA, BYRN, OCX, BBVA and HMY have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2025.
Read More
CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement
Published: May 05, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement.
Read More
MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Positive
MAIA Biotechnology, Inc. (MAIA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025
Published: March 25, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025.
Read More
MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million
Published: February 24, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million.
Read More
MAIA Biotechnology Announces Private Placement of $2,715,000
Published: February 18, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces Private Placement of $2,715,000.
Read More
About MAIA Biotechnology, Inc. (MAIA)
- IPO Date 2022-07-28
- Website https://www.MAIABiotech.com
- Industry Biotechnology
- CEO Dr. Vlad Vitoc M.B.A., M.D.
- Employees 13